Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TYMS | P04818 | 1/20 | 0.41 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.39 |
| ▸ | TK1 | P04183 | 1/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8328237 | 1.00 | LMNA (0.46) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8329355 | 0.94 | LMNA (0.45) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8329352 | 0.94 | LMNA (0.45) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8327950 | 0.92 | LMNA (0.47) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8327954 | 0.92 | LMNA (0.47) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8325806 | 0.89 | RNASE1 (0.44) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8325808 | 0.89 | RNASE1 (0.44) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8327674 | 0.89 | LMNA (0.48) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8327670 | 0.89 | LMNA (0.48) | LMNASMN1; SMN2TYMSRNASE1TK1 | |
| SCHEMBL8328409 | 0.89 | RNASE1 (0.47) | LMNASMN1; SMN2TYMSRNASE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5869464-A | HAVING LOW TOXICITY, SUSTAINING LOW CONCENTRATION IN BLOOD FOR EXTENDED PERIOD | TAIHO PHARMACEUTICAL CO. LTD. (JP) | 1999-02-09 | — | — | US | disclosed |
| EP-0686641-B1 | 2'-DEOXY-5-FLUOROURIDINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING THE SAME, AND ANTITUMOR DRUG | TAIHO PHARMACEUTICAL CO LTD (JP) | 1998-08-26 | — | — | EP | disclosed |
| EP-0686641-A1 | 2'-DEOXY-5-FLUOROURIDINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING THE SAME, AND ANTITUMOR DRUG | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-12-13 | — | — | EP | disclosed |